Differentially expressed transcripts associated with depressive symptoms during pregnancy and postpartum

Area of Science:

• Reproductive Medicine
• Genetics
• Psychiatry

Background:

• Peripartum depression significantly impacts maternal and infant well-being.
• The biological mechanisms underlying peripartum depression remain largely unelucidated.
• Identifying molecular signatures can aid in understanding and potentially treating this condition.

Purpose of the Study:

• To identify transcriptomic signatures associated with depressive symptoms during pregnancy and the postpartum period.
• To investigate the relationship between gene expression profiles and the severity of depressive symptoms.
• To explore the role of immune system dysregulation in peripartum depression.

Main Methods:

• Blood samples were collected from women during late pregnancy or early postpartum.
• Messenger RNA (mRNA) was isolated for sequencing to identify differentially expressed genes (DEGs).
• Depressive symptoms were quantified using the Edinburgh Postnatal Depression Scale (EPDS).

Main Results:

• Transcriptomic signatures linked to depressive symptoms were identified, particularly in samples from late pregnancy.
• A significant number of upregulated and downregulated DEGs were associated with EPDS scores during pregnancy.
• Gene Set Enrichment Analysis revealed immune response and cell motility as key biological processes involved.
• Previously identified immune-related genes (ISG15, RSAD2) showed a positive association with postpartum depressive symptoms.

Conclusions:

• Peripartum depressive symptoms are associated with distinct transcriptomic signatures, primarily involving immune system dysregulation.
• These findings highlight the potential role of immune pathways in the pathophysiology of peripartum depression.
• Further research into these molecular pathways may lead to novel diagnostic or therapeutic strategies.